COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 299.9 | 5 | 0158-0679 | 451.47 | 679.38 | 325 | 69.84 | 0.837 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 4268.5 | 5 | 0159-0684 | 636.39 | 684.58 | 320 | 66.18 | 0.918 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 767.8 | 5 | 0160-0696 | 906.66 | 696.33 | 348 | 73.01 | 0.820 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.2 | 6 | 0001-0040 | 323.34 | 40.63 | 347 | 73.01 | 0.818 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 428.2 | 6 | 0002-0047 | 782.00 | 47.24 | 273 | 67.26 | 0.758 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 505.4 | 6 | 0003-0053 | 426.76 | 53.37 | 270 | 66.67 | 0.763 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 395.0 | 6 | 0004-0055 | 149.57 | 55.43 | 286 | 63.94 | 0.879 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 273.5 | 6 | 0005-0060 | 25.83 | 60.11 | 304 | 64.77 | 0.911 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 467.3 | 6 | 0006-0061 | 823.37 | 60.79 | 253 | 65.84 | 0.733 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 571.9 | 6 | 0007-0067 | 247.36 | 66.94 | 265 | 65.60 | 0.774 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 281.3 | 6 | 0008-0077 | 673.88 | 77.38 | 377 | 71.84 | 0.918 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 273.9 | 6 | 0009-0084 | 318.86 | 83.55 | 340 | 71.26 | 0.842 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 531.7 | 6 | 0010-0082 | 527.49 | 83.00 | 305 | 64.77 | 0.914 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 354.8 | 6 | 0011-0087 | 691.40 | 87.25 | 305 | 68.43 | 0.819 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 370.0 | 6 | 0012-0093 | 196.33 | 91.42 | 299 | 70.18 | 0.763 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 491.8 | 6 | 0013-0093 | 411.70 | 93.66 | 250 | 59.60 | 0.884 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 577.1 | 6 | 0014-0104 | 612.42 | 106.23 | 346 | 102.23 | 0.416 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 259.4 | 6 | 0015-0107 | 853.40 | 107.97 | 367 | 72.18 | 0.885 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 518.7 | 6 | 0016-0113 | 298.91 | 113.41 | 347 | 71.84 | 0.845 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 322.9 | 6 | 0017-0113 | 172.37 | 112.80 | 285 | 62.77 | 0.909 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 527.1 | 6 | 0018-0114 | 334.39 | 113.57 | 226 | 58.53 | 0.829 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 412.1 | 6 | 0019-0121 | 811.87 | 120.64 | 294 | 66.77 | 0.829 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 357.8 | 6 | 0020-0128 | 489.88 | 127.29 | 314 | 69.50 | 0.817 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 361.0 | 6 | 0021-0127 | 261.73 | 127.59 | 320 | 69.01 | 0.844 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 316.3 | 6 | 0022-0130 | 584.41 | 129.80 | 379 | 79.50 | 0.754 |